These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Conorphin-66 produces peripherally restricted antinociception via the kappa-opioid receptor with limited side effects. Xu K; Zhang M; Chen D; Xu B; Hu X; Zhang Q; Zhang R; Zhang N; Li N; Fang Q Neuropharmacology; 2024 Dec; 261():110157. PubMed ID: 39276862 [TBL] [Abstract][Full Text] [Related]
3. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287 [TBL] [Abstract][Full Text] [Related]
4. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential. Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307 [TBL] [Abstract][Full Text] [Related]
5. Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch. Wang X; Gou X; Yu X; Bai D; Tan B; Cao P; Qian M; Zheng X; Wang H; Tang P; Zhang C; Ye F; Ni J Front Pharmacol; 2021; 12():773204. PubMed ID: 34867403 [TBL] [Abstract][Full Text] [Related]
6. OCP002, a Mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception With Minimized Side Effects. Xu B; Zhang Q; Chen D; Zhang M; Zhang R; Zhao W; Qiu Y; Xu K; Xiao J; Niu J; Shi Y; Li N; Fang Q Anesth Analg; 2023 Feb; 136(2):373-386. PubMed ID: 36638515 [TBL] [Abstract][Full Text] [Related]
7. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor. Schattauer SS; Kuhar JR; Song A; Chavkin C Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389 [TBL] [Abstract][Full Text] [Related]
8. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors. Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309 [TBL] [Abstract][Full Text] [Related]
13. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors. Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977 [TBL] [Abstract][Full Text] [Related]
14. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities. Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462 [TBL] [Abstract][Full Text] [Related]